$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Allergic rhinitis in children 원문보기

Journal of paediatrics and child health, v.48 no.4, 2012년, pp.302 - 310  

Turner, Paul J (Department of Allergy and Immunology, The Children's Hospital at Westmead and University of Sydney, Sydney, New South Wales, Australia) ,  Kemp, Andrew S (Department of Allergy and Immunology, The Children's Hospital at Westmead and University of Sydney, Sydney, New South Wales, Australia)

Abstract AI-Helper 아이콘AI-Helper

Allergic rhinitis affects up to 40% of children but is commonly undiagnosed. Careful assessment of nasal symptoms allows for the most appropriate therapeutic options to be chosen. Allergen avoidance is often difficult in practice. Antihistamines are of limited benefit in allergic rhinitis caused by ...

주제어

참고문헌 (46)

  1. 1 Strachan D , Sibbald B , Weiland S et al . Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) . Pediatr. Allergy Immunol. 1997 ; 8 : 161 – 76 . 

  2. 2 Ait‐Khaled N , Anderson HR , Asher MI et al . Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood . Pediatr. Allergy Immunol. 2007 ; 19 : 110 – 24 . 

  3. 3 Hamouda S , Karila C , Connault T , Scheinmann P , de Blic J . Allergic rhinitis in children with asthma: a questionnaire‐based study . Clin. Exp. Allergy 2008 ; 38 : 761 – 6 . 

  4. 4 Taramarcaz P , Gibson PG . The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome . Clin. Exp. Allergy 2004 ; 34 : 1883 – 9 . 

  5. 5 Rachelefsky GS , Goldberg M , Katz RM et al . Sinus disease in children with respiratory allergy . J. Allergy Clin. Immunol. 1978 ; 61 : 310 – 4 . 

  6. 6 Rachelefsky GS . National guidelines needed to manage rhinitis and prevent complications . Ann. Allergy Asthma Immunol. 1999 ; 82 : 296 – 305 . 

  7. 7 Yuksel H , Sogut A , Yilmaz H , Yilmaz O , Dinc G . Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis . Ann. Allergy Asthma Immunol. 2009 ; 103 : 290 – 4 . 

  8. 8 Vuurman EFPM , van Veggel LMA , Uiterwijk MMC , Leutner D , O'Hanlon JF . Seasonal allergic rhinitis and antihistamine effects on children's learning . Ann. Allergy 1993 ; 71 : 121 – 6 . 

  9. 9 Turner PJ , Foreman JC . Hyperresponsiveness in the human nasal airway – new targets for the treatment of allergic airway disease . Mediators Inflamm. 1999 ; 8 : 133 – 46 . 

  10. 10 Graft D , Aaronson D , Chervinsky P et al . A placebo‐ and active‐controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray . J. Allergy Clin. Immunol. 1996 ; 98 : s 724 – 31 . 

  11. 11 Turner P , Dear J , Scadding G et al . Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen . J. Allergy Clin. Immunol. 2001 ; 107 : 105 – 13 . 

  12. 12 Maruo K , Akaike T , Matsumura Y et al . Triggering of the vascular permeability reaction by activation of the Hageman factor‐prekallikrein system by house dust mite proteinase . Biochim. Biophys. Acta. 1991 ; 1074 : 62 – 8 . 

  13. 13 Scadding GK , Durham SR , Mirakian R et al . BSACI guidelines for the management of allergic and non‐allergic rhinitis . Clin. Exp. Allergy 2008 ; 38 : 19 – 42 . 

  14. 14 Ponsonby A‐L , Dwyer T , Kemp A , Lim L , Cochrane J , Carmichael A . The use of mutually exclusive categories for atopic sensitization: a contrasting effect for family size on house dust mite sensitization compared with ryegrass sensitization . Pediatr. Allergy Immunol. 2003 ; 14 : 81 – 90 . 

  15. 15 Droste JH , Kerhof M , de Monchy JG , Schouten JP , Rijcken B . Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community‐based population study. The Dutch ECRHS Group . J. Allergy Clin. Immunol. 1996 ; 97 : 922 – 32 . 

  16. 16 Gleeson M , Cripps AW , Hensley MJ , Wlodarczyk JH , Henry RL , Clancy RL . A clinical evaluation in children of the Pharmacia ImmunoCAP system for inhalant allergens . Clin. Exp. Allergy 1996 ; 26 : 697 – 702 . 

  17. 17 Sheikh A , Hurwitz B , Shehata Y . House dust mite avoidance measures for perennial allergic rhinitis . Cochrane Database Syst. Rev. 2007 ; 1 : CD001563 . 

  18. 18 O'Meara TJ , Sercombe JK , Morgan G , Reddel HK , Xuan W , Tovey ER . The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen . Allergy 2005 ; 60 : 529 – 32 . 

  19. 19 Egmar AC , Emenius G , Almqvist C , Wickman M . Cat and dog allergen in mattresses and textile covered floors of homes which do or do not have pets, either in the past or currently . Pediatr. Allergy Immunol. 1998 ; 9 : 31 – 5 . 

  20. 20 Gani F , Pozzi E , Crivellaro MA et al . The role of patient training in the management of seasonal allergic rhinitis and asthma: clinical implications . Allergy 2001 ; 56 : 65 – 8 . 

  21. 21 Dykewicz MS , Fineman S , Skoner DP et al . Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma, and Immunology . Ann. Allergy Asthma Immunol. 1998 ; 81 : 478 – 518 . 

  22. 22 Salib RJ , Howarth PH . Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis . Drug. Saf. 2003 ; 26 : 863 – 93 . 

  23. 23 Al Sayyad JJ , Fedorowicz Z , Alhashimi D , Jamal A . Topical nasal steroids for intermittent and persistent allergic rhinitis in children . Cochrane Database Syst. Rev. 2007 ; 1 : CD003163 . 

  24. 24 Weiner JM , Abramson MJ , Puy RM . Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials . BMJ 1998 ; 317 : 1624 – 9 . 

  25. 25 Yanez A , Rodrigo GJ . Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with metaanalysis . Ann. Allergy Asthma Immunol. 2002 ; 89 : 479 – 84 . 

  26. 26 Scadding G . Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments . Paediatr. Drugs 2008 ; 10 : 151 – 62 . 

  27. 27 Price D , Bond C , Bouchard J et al . International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis . Prim. Care Respir. J. 2006 ; 15 : 58 – 70 . 

  28. 28 Allen DB , Meltzer EO , Lemanske RF et al . No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year . Allergy Asthma Proc. 2002 ; 23 : 407 – 13 . 

  29. 29 Schenkel EJ , Skoner DP , Bronsky EA et al . Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray . Pediatrics 2000 ; 105 : E22 . 

  30. 30 Möller C , Ahlström H , Henricson KA et al . Safety of nasal budesonide in the long term treatment of children with perennial rhinitis . Clin. Exp. Allergy 2003 ; 33 : 816 – 22 . 

  31. 31 Schad CA , Skoner DP . Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria . Allergy Asthma Proc. 2008 ; 29 : 7 – 13 . 

  32. 32 Simons FE . Prospective, long‐term safety evaluation of the H1‐receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child . J. Allergy Clin. Immunol. 1999 ; 104 : 433 – 40 . 

  33. 33 Ratner PH , Hampel F , Van Bavel J et al . Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis . Ann. Allergy Asthma Immunol. 2008 ; 100 : 74 – 81 . 

  34. 34 Chen ST , Lu KH , Sun HL , Chang WT , Lue KH , Chou MC . Randomized placebo‐controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2–6 yr . Pediatr. Allergy Immunol. 2006 ; 17 : 49 – 54 . 

  35. 35 Di Lorenzo G , Pacor ML , Pellitteri ME et al . Randomized placebo‐controlled trial comparing fluticasone aqueous nasal spray in mono‐therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis . Clin. Exp. Allergy 2004 ; 34 : 259 – 67 . 

  36. 36 Keskin O , Alyamac E , Tuncer A , Dogan C , Adalioglu G , Sekerel BE . Do the leukotriene receptor antagonists work in children with grass pollen‐induced allergic rhinitis? Pediatr. Allergy Immunol. 2006 ; 17 : 259 – 68 . 

  37. 37 Rouse R . Tighter restrictions planned for kids' cough meds . Medical Observer 2009 30 October. Available from: http://www.medicalobserver.com.au/news/tighter‐restrictions‐planned‐for‐kids‐cough‐meds. 

  38. 38 Calderon MA , Alves B , Jacobson M , Hurwitz B , Sheikh A , Durham S . Allergen injection immunotherapy for seasonal allergic rhinitis . Cochrane Database Syst. Rev. 2007 ( 1 ); CD001936 . 

  39. 39 Roder E , Berger MY , de Groot H , van Wijk RG . Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review . Pediatr. Allergy Immunol. 2008 ; 19 : 197 – 207 . 

  40. 40 Rodriguez‐Perez N , Ambriz‐Moreno MJ , Canonica GW , Penagos M . Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy . Ann. Allergy Asthma Immunol. 2008 ; 101 : 304 – 10 . 

  41. 41 Campbell DE . Sublingual immunotherapy for children: are we there yet? Defining its role in clinical practice . Paediatr. Respir. Rev. 2009 ; 10 : 69 – 74 . 

  42. 42 Wahn U , Tabar A , Kuna P et al . Efficacy and safety of 5‐grass‐pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis . J. Allergy Clin. Immunol. 2009 ; 123 : 160 – 6 . 

  43. 43 Bufe A , Eberle P , Franke‐Beckmann E et al . Safety and efficacy in children of an SQ‐standardized grass allergen tablet for sublingual immunotherapy . J. Allergy Clin. Immunol. 2009 ; 123 : 167 – 73 . 

  44. 44 Larenas‐Linnemann D . Sublingual immunotherapy in children: complete and updated review supporting evidence of effect . Curr. Opin. Allergy Clin. Immunol. 2009 ; 9 : 168 – 76 . 

  45. 45 Marogna M , Tomassetti D , Bernasconi A et al . Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study . Ann. Allergy Asthma Immunol. 2008 ; 101 : 206 – 11 . 

  46. 46 Jacobsen L , Niggemann B , Dreborg S et al . Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study . Allergy 2007 ; 62 : 943 – 8 . 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로